Last $0.68 USD
Change Today +0.03 / 4.62%
Volume 13.2K
FPMI On Other Exchanges
Symbol
Exchange
OTC BB
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

fluoropharma medical inc (FPMI) Key Developments

FluoroPharma Medical, Inc. and The General Hospital Corporation Entered into Two License Agreements

On June 26, 2014, FluoroPharma Medical, Inc. and The General Hospital Corporation, d/b/a Massachusetts General Hospital (MGH) entered into two license agreements which Agreements replace the single license agreement between the Company and MGH dated April 27, 2009, as amended by letter dated June 21, 2011 and agreement dated October 31, 2011. The Agreements provide exclusive licenses for two lead product candidates, BFPET and CardioPET, two of the three cardiac imaging technologies covered by the Original Agreement. The Company and MGH are in discussions regarding the exclusive license to VasoPET, the third product candidate covered by the Original Agreement, rights to which ceased upon the termination of the Original Agreement contemporaneously with the execution of the new Agreements. The Agreements were entered into primarily for the purpose of separating the Company's rights and obligations with respect to its different product development programs. Each of the Agreements requires to pay MGH an initial license fee of $175,000 and annual license maintenance fees aggregating $250,000. The Agreements require to meet certain obligations, including, but not limited to, meeting certain development milestones relating to clinical trials and filings with the United States Food and Drug Administration.

Fluoropharma Medical, Inc. Presents Data from Phase II Clinical Trial of 18F FCPHA

FluoroPharma Medical, Inc. announced that data and analysis from a feasibility study on the quantification of myocardial perfusion in humans by PET/CT utilizing the fatty acid analogue (18) F-FCPHA at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting.

FluoroPharma Medical, Inc. Presents at 15th Annual B. Riley & Co. Investor Conference, May-19-2014 04:00 PM

FluoroPharma Medical, Inc. Presents at 15th Annual B. Riley & Co. Investor Conference, May-19-2014 04:00 PM. Venue: Loews Santa Monica Beach Hotel, 1700 Ocean Avenue, Santa Monica, CA 90401, United States. Speakers: Johan M. Spoor, Chairman, Chief Executive Officer and President.

FluoroPharma Medical, Inc. Presents at LD MICRO 4th Annual Micro-Cap Invitational, Jun-04-2014 09:00 AM

FluoroPharma Medical, Inc. Presents at LD MICRO 4th Annual Micro-Cap Invitational, Jun-04-2014 09:00 AM. Venue: Luxe Sunset Bel Air, 11461 Sunset Boulevard, Los Angeles, CA 90049, United States.

FluoroPharma Medical, Inc. Appoints H. William Strauss to Chair the Scientific Advisory Board

FluoroPharma Medical, Inc. announced that Dr. H. William Strauss has been appointed to chair the company's scientific advisory board. Dr. Strauss currently serves as an Attending Physician Emeritus of the Molecular Imaging and Therapy Nuclear Medicine Service at Memorial Sloan Kettering Cancer Center & Memorial Hospital in New York City. He joined the Memorial Sloan Kettering/Cornell faculty and staff in 2001, following 30 years of faculty, clinical and research appointments in radiology at the medical schools and teaching hospitals of Johns Hopkins, Harvard, Stanford and Cornell University medical centers. For two years in the early 1990s, he also served as Vice President-Diagnostics Drug Discovery for Bristol-Myers Squibb Co.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FPMI:US $0.68 USD +0.03

FPMI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for FPMI.
View Industry Companies
 

Industry Analysis

FPMI

Industry Average

Valuation FPMI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FLUOROPHARMA MEDICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.